Concepedia

Sergey Aksenov

SA

Statistics

Publications

12

Citations

405

H-Index

12

Active since

1997

Affiliations

AstraZeneca (United States)(Current)

Joint Institute for Nuclear Research

Novartis (Switzerland)

University of Cambridge

Sergey Aksenov is an author at AstraZeneca (United States) specializing in medicine, pharmacology, and microbiology.

ORCID

Top concepts

Publications per year

1997–2021

12

Publications

12

A Spatially Extended Stochastic Model of the Bacterial Chemotaxis Signalling Pathway

Thomas Shimizu, Sergey Aksenov, Dennis Bray · Journal of Molecular Biology · 2003 · 147 citations

, , +4

A systems biology dynamical model of mammalian G <sub>1</sub> cell cycle progression

Thomas Haberichter, Britta Mädge, Renee A. Christopher et al. · Molecular Systems Biology · 2007 · 63 citations · Full text

Application of the combined nonlinear-condensation transformation to problems in statistical analysis and theoretical physics

Sergey Aksenov, Michael A. Savageau, Ulrich D. Jentschura et al. · Computer Physics Communications · 2002 · 29 citations · Full text

, , +10

Longitudinal Tumor Size and Neutrophil‐to‐Lymphocyte Ratio Are Prognostic Biomarkers for Overall Survival in Patients With Advanced Non‐Small Cell Lung Cancer Treated With Durvalumab

S. V. Gavrilov, Kirill Zhudenkov, Gabriel Helmlinger et al. · CPT Pharmacometrics & Systems Pharmacology · 2020 · 27 citations · Full text

Dynamics of the inducing signal for the SOS regulatory system in Escherichia coli after ultraviolet irradiation

Sergey Aksenov · Mathematical Biosciences · 1999 · 25 citations

, , +7

1–5 of 12